SC
Steven Cohen (Point72) disclosed new in CATALYST PHARMACEUTICALS INC
Steven Cohen (Point72) filed a 13F change in CATALYST PHARMACEUTICALS INC (14888U101) on 2026-05-15, covering period end 2026-03-31.
Action
New
Capital
$10,544,417 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.